Press Releases
Avedro Announces the Start of Two New US FDA...
Avedro Inc. a Boston-based ophthalmic medical device and pharmaceutical company announces today that the first patients have been treated in two new US clinical trials:...
Press Releases
Advanced research instrumentation pioneer Oxford Optronix launches HypoxyLab™ –...
Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™ –...
Press Releases
Promethera Biosciences successfully enrols twenty patients in its multicentric...
Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases. ...
Press Releases
Neuroptis Biotech announces the preclinical results for its dry...
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is...
Press Releases
PathoQuest and Covance to offer Next-Generation Sequencing-based biosafety assessments
Covance Inc. , one of the world's largest and most comprehensive drug development companies, and PathoQuest, a pioneer in the field of pathogen detection, today...
Press Releases
Trophos completes pivotal phase II/III study of olesoxime in...
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has...
Press Releases
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen...
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.